Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,208.06 | 1,554.91 | 2,751.62¢ | 15.8 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,380.12 | 1,621.14 | 2,852.65¢ | 15.2 | 4.1 | +4% | n/a | 0.0% |
31-Dec-27 | 3,551.47 | 1,654.26 | 2,811.12¢ | 15.4 | n/a | -2% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 434.06 |
Change Today | $ 19.33 |
% Change | 4.66 % |
52 Week High | $438.26 |
52 Week Low | $274.70 |
Volume | 873 |
Shares Issued | 43.56m |
Market Cap | $18,909m |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
You are here: research